Ryll Thomas 4
4 · IMMUNOGEN INC · Filed Feb 25, 2019
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Ryll Thomas
VP, Technical Operations
Transactions
- Sale
Common Stock
2018-02-22$5.60/sh−11,495$64,372→ 87,184 total
Footnotes (2)
- [F1]Weighted average price of shares sold.
- [F2]The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.